CPhI Online

- Conference & Exhibition

UPDATED: The CPhI Discover Blog

Gareth Carpenter — 20 May 2021

Bookmark this page for regular updates on the rich variety of content coming your way via CPhI Discover, pharma’s largest ever virtual gathering, over the course of our three-day agenda

Pharma’s largest ever virtual gathering, CPhI Discover, kicks off on Monday, May 17. We have a packed three-day content agenda running from Tuesday, May 18 – Thursday May 21, full of webinars, podcasts and learning labs delivered by industry experts and thought leaders and offering industry insights across drug manufacturing, outsourcing, pharma ingredients, drug delivery and packaging.

When it comes to holding in-person physical events for the pharmaceutical ingredients and outsourcing sectors, the green shoots of recovery are now visible.

In April, Informa Markets’ held its first in-person trade show of 2021, opening its doors to attendees of CPhI Japan in Tokyo. It was a fitting outcome, given that CPhI Japan was the first trade show we had to cancel last year due to the COVID-19 pandemic and ensuing travel restrictions.

With several more events planned for later in the year, including the much anticipated CPhI Worldwide in Milan, Italy in November, Informa Markets is very much looking forward to meeting you in person once again.

But for now, enjoy what we have to offer you in the way of CPhI Discover.

Thursday May 20 AM

In yesterday's live session on drug delivery startups, part of the discussion centred on the benefits and considerations of outsourcing manufacturing. Read the news article here.

Today we have a session which will explore the fast-growing global market in vitamins in terms of the impact of new products as well as China’s role as the world largest manufacturing region for the sector. Our panel of experts comprises Ellie Adams from QIVA, Yukihiro Miyazaki from Jupiter Bioscience Japan and Vinita Satyavrat from Dr. Reddy’s.

Savvy consumers in search of more sustainable and cleaner beauty products that contain new natural ingredients are driving growing demand in the cosmeceuticals sector, and today’s session Formulating Natural Ingredients for Cosmeceuticals features industry experts, Akshay Talati at L'Oréal, Sylesh Venkataraman at Lubrizol Life Science- Beauty, and Pushpa Vijayaraghavan at Sathguru Management Consultants.

Our third and final formulation podcast is an interview with Stefano Console from Oriento, who will run us through spray drying, a highly popular manufacturing technique for producing formulations of poorly soluble APIs and inhalable dry powders.

And to round off the day, our live panel session The API Landscape – Reshoring, Trading & Sourcing Dynamics promises to explore the key issues around ingredient manufacturing and sourcing and supply chain resiliency in a sector that is constantly having to meet shifting demand patterns. The panel comprises Brandon Boyd from Clarivate, Aurelio Arias from IQVIA, Matt Hicks from Federal Equipment Company and Stefan Schmidinger from Kemiex.

And just a reminder that all content will be made available on demand from May 31 but why wait? Register for the event here and be sure to check out the CPhI Discover agenda for the wealth of content available at your fingertips in an instant.

Wednesday May 19 PM

Read our summary of yesterday’s incredibly insightful live session, Navigating the CDMO Market: Hurdles, Transformation and Opportunities, here

Wednesday May 19 AM

In the second day of our content agenda, Christian Sandmann, R&D Associate Director, BD Medical – Pharmaceutical Systems delivers a presentation on Patient-Centric Drug Delivery Solutions for Self-Administration. The current trend towards self-administration of drugs at home, exacerbated by the current coronavirus pandemic, is driving demand for drug delivery devices for subcutaneous administration of the growing number of biotherapeutics.

Read the news article of the Patient Centric delivery Solutions webinar here.

Our next podcast on the theme of formulation approaches and challenges centres firmly on the subject of co-crystals. We speak to Asha Pharma Founder and CEO, Andy Singh about how the use of co-crystals has evolved and what are the best approaches to screening and selecting co-crystals to identify the most viable ones to help find suitable development candidates.

Ready-to-administer-systems such as pre-fillable syringes can provide benefits to numerous stakeholders including reduction in medication errors, risk of contamination and nurse saving time. Tune into the webinar, Vial to Ready-To-Administer Need and BD solution offerings in acute care, where Sagar Bejalwar, Senior Manager, Global Acute and Specialty Portfolio Marketing at BD Medical - Pharmaceutical Systems speaks about the benefits of using ready-to-administer systems for intravenous drugs.

Read the news article of the Vial to Ready-To-Administer Need and BD solution offerings in acute care webinar here.

And don't miss our live session today at 15:00 CET, Drug Delivery Start-Ups to Watch in 2021 and Beyond, in which a panel of experts will identify and discuss the opportunities and challenges in the drug delivery technology landscape.  Featuring Mahmoud Ameri from Zosano Pharma, Jose Ochoa from Altimmune, Wayne Weiner from Pharmatech Solutions and Don Zinn from Crossject.

Tuesday May 18

Welcome to the first day of content at CPhI Discover! In today's proceedings, Reena Gandhi from Aptar Pharma and Laura Kleinman from Reboot Rx run the rule over drug repurposing and examine all the challenges and benefits of taking this pathway as opposed to the 'traditional' drug development process.

Read the news article of the Drug Repurposing session here.

Opportunities for CDMOs operating in China have never been better since recent legislation - the Market Authorisation Holder system -- came into play, allowing pharma companies to use a contract manufacturer as opposed to the previously mandatory in-house production. Don't miss our session today, China: Evolving Dynamics of the CDMO Landscape in which Eric Sun from Zhejiang Langhua Pharmaceutical and Vicky Xia from BioPlan Associates assess the positioning, strengths and weakenesses of the Chinese CDMO industry.

The subject of Brexit continues to stir debate, and in a forward-looking webinar today, Beyond Brexit: The Future of British Pharma, three experts -- Virginia Acha at MSD, Peter Gough at NSF International and Angela Macfarlane at IQVIA will assess what the potential UK pharma landscape is going to look like in terms of clinical research, regulatory affairs, investment and trade.

Read the news article of the Brexit session here.

Our in-event podcast series focuses on formulation approaches and technologies and today, Bruce Frank from Lubrizol Life Science Health explores how Hot Melt Extrusion has developed as proven technology for bioavailability enhancement of poorly soluble active pharmaceutical ingredients, and how it stacks up against other formulation options in terms of cost and scalability in order to deliver high quality, commercialised pharmaceutical products.

All content will be made available on demand from May 31 but why wait? Register for the event here and be sure to check out the CPhI Discover agenda for the wealth of content available at your fingertips throughout the day.

Wednesday May 12

Listen to this podcast in which Informa Markets’ Tara Dougal and Gareth Carpenter shoot the breeze on what to expect from the CPhI Discover content programme over the coming days.

Manufacturing and Outsourcing will be the main content track on Tuesday. Head here for a strong overview of the current major trends and issues including manufacturing technology, strategic CDMO partnerships, industry consolidation and local sourcing.

Wednesday’s main content track is Drug Delivery and Packaging. Read this article on how technology innovation and patient centric routes of administration are producing a new generation of devices as well as the effects of the US Drug Supply Chain Security Act on the packaging sector.

Our final track is APIs, Ingredients & Formulation, which will dominate Thursday’s proceedings. For a concise summary of how advances in the pharmaceutical R&D lab are impacting firms that manufacture APIs and excipients and those that provide formulation development services, click here.

Related Content